Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Fontaine, Véronique"'
Autor:
Zeng S; Microbiology, Bioorganic and Macromolecular Chemistry Research Unit, Faculté de Pharmacie, Université Libre de Bruxelles, Brussels, Belgium., Soetaert K; Sciensano, Tuberculosis and Mycobacteria Unit, Brussels, Belgium., Ravon F; Microbiology, Bioorganic and Macromolecular Chemistry Research Unit, Faculté de Pharmacie, Université Libre de Bruxelles, Brussels, Belgium., Vandeput M; Pharmacognosy, Bioanalysis and Drug Discovery Research Unit, Faculté de Pharmacie, Université Libre de Bruxelles, Brussels, Belgium., Bald D; Department of Molecular Cell Biology, Amsterdam Institute for Molecules, Medicines and Systems, Faculty of Earth and Life Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Kauffmann JM; Pharmacognosy, Bioanalysis and Drug Discovery Research Unit, Faculté de Pharmacie, Université Libre de Bruxelles, Brussels, Belgium., Mathys V; Sciensano, Tuberculosis and Mycobacteria Unit, Brussels, Belgium., Wattiez R; Department of Proteomics and Microbiology, University of Mons, Mons, Belgium., Fontaine V; Microbiology, Bioorganic and Macromolecular Chemistry Research Unit, Faculté de Pharmacie, Université Libre de Bruxelles, Brussels, Belgium vfontain@ulb.ac.be.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2019 Feb 26; Vol. 63 (3). Date of Electronic Publication: 2019 Feb 26 (Print Publication: 2019).
Autor:
Rens C; Université Libre de Bruxelles (ULB), Unit of Pharmaceutical Microbiology and Hygiene, Brussels, Belgium., Laval F; Institute of Pharmacology and Structural Biology, University of Toulouse, CNRS, University Paul Sabatier (UMR 5089), Department of Tuberculosis and Infection Biology, Toulouse Cedex 04, France., Daffé M; Institute of Pharmacology and Structural Biology, University of Toulouse, CNRS, University Paul Sabatier (UMR 5089), Department of Tuberculosis and Infection Biology, Toulouse Cedex 04, France., Denis O; Laboratory of Bacteriology, Department of Microbiology, Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium., Frita R; Institut Pasteur de Lille, Université de Lille, CNRS, INSERM, CHU Lille, U1019-UMR 8204, Center for Infection and Immunity of Lille, Lille, France., Baulard A; Institut Pasteur de Lille, Université de Lille, CNRS, INSERM, CHU Lille, U1019-UMR 8204, Center for Infection and Immunity of Lille, Lille, France., Wattiez R; Department of Proteomics and Microbiology, University of Mons, Mons, Belgium., Lefèvre P; Université Libre de Bruxelles (ULB), Unit of Pharmaceutical Microbiology and Hygiene, Brussels, Belgium., Fontaine V; Université Libre de Bruxelles (ULB), Unit of Pharmaceutical Microbiology and Hygiene, Brussels, Belgium vfontain@ulb.ac.be.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2016 Sep 23; Vol. 60 (10), pp. 6193-9. Date of Electronic Publication: 2016 Sep 23 (Print Publication: 2016).
Autor:
Soetaert K; Scientific Institute of Public Health (WIV-ISP), Operational Direction of Communicable and Infectious Diseases, Brussels, Belgium., Rens C; Université Libre de Bruxelles (ULB), Unit of Pharmaceutical Microbiology and Hygiene, Brussels, Belgium., Wang XM; Scientific Institute of Public Health (WIV-ISP), Operational Direction of Communicable and Infectious Diseases, Brussels, Belgium., De Bruyn J; Université Libre de Bruxelles (ULB), Unit of Pharmaceutical Microbiology and Hygiene, Brussels, Belgium., Lanéelle MA; Tuberculosis and Infection Biology (TBIB), Institute of Pharmacology and Structural Biology of CNRS and the University Paul Sabatier (UMR 5089), Toulouse, France., Laval F; Tuberculosis and Infection Biology (TBIB), Institute of Pharmacology and Structural Biology of CNRS and the University Paul Sabatier (UMR 5089), Toulouse, France., Lemassu A; Tuberculosis and Infection Biology (TBIB), Institute of Pharmacology and Structural Biology of CNRS and the University Paul Sabatier (UMR 5089), Toulouse, France., Daffé M; Tuberculosis and Infection Biology (TBIB), Institute of Pharmacology and Structural Biology of CNRS and the University Paul Sabatier (UMR 5089), Toulouse, France., Bifani P; Novartis Institute for Tropical Diseases (NITD), Singapore, Singapore., Fontaine V; Université Libre de Bruxelles (ULB), Unit of Pharmaceutical Microbiology and Hygiene, Brussels, Belgium., Lefèvre P; Université Libre de Bruxelles (ULB), Unit of Pharmaceutical Microbiology and Hygiene, Brussels, Belgium philefev@ulb.ac.be.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2015 Aug; Vol. 59 (8), pp. 5057-60. Date of Electronic Publication: 2015 Jun 01.
Autor:
Fontaine V; Laboratory of Molecular Virology, ISP/Institut Pasteur, rue Engeland 642, 1180 Brussels, Belgium. vfontaine@pasteur.be, Mascaux C, Weyn C, Bernis A, Celio N, Lefèvre P, Kaufman L, Garbar C
Publikováno v:
Journal of clinical microbiology [J Clin Microbiol] 2007 Mar; Vol. 45 (3), pp. 928-34. Date of Electronic Publication: 2007 Jan 17.